Biovinate
Formulation
Each 15 mL solution for intravenous infusion contains:
Carboplatin 150 mg

 

 

Each 45 mL solution for intravenous infusion contains:
Carboplatin 450 mg

 

 

Carboplatin

Biovinate®

Prescription Drug

Indication

  • Initial treatment of advanced ovarian carcinoma of epithelial origin in established combinations with other approved chemotherapeutic agents
  • For the palliative treatment of ovarian carcinoma of epithelial origin refractory to standard chemotherapy with or without cisplatin
  • For the treatment of small cell lung carcinoma

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.